drugset / Trial / NCT04190173
Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Paralytic ileus is a common intestinal dysfunction in critically ill patients. There are still no established the effective medications except correcting the primary causes and prokinetics trial which limited in efficacy and potential adverse events.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2020-01-30
- Completion
- 2020-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prucalopride | Small molecule | 1 mg | Oral |
| Subject | Prucalopride | Small molecule | 2 mg | Oral |